New Agents and Evolving Strategies in Prostate Cancer: Focus on Castration-Sensitive Disease

Learn how experts select and carefully consider the toxicity profiles of established and newly emerging androgen-deprivation therapies toward the optimal management of patients with castration-sensitive prostate cancer. Download slides from the live symposium and read an expert-authored commentary on androgen-deprivation therapies for castration-sensitive prostate cancer.

Share

Program Content

Activities

Management of CSPC
New Agents and Evolving Strategies in Prostate Cancer: Focus on Castration-Sensitive Disease
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 14, 2022

Expires: March 13, 2023

View Activity

Activities

CSPC: Overview of Management
Overview of Recurrent and Metastatic Castration-Sensitive Prostate Cancer Management
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2022

Expires: February 17, 2023

View Activity
CSPC: Comparison of ADTs
Comparison of Androgen-Deprivation Therapies for CSPC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2022

Expires: February 17, 2023

View Activity
CSPC: Evolving Treatments
New Agents and Evolving Strategies for CSPC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2022

Expires: February 17, 2023

View Activity

Activities

ADT Strategies for CSPC
New Agents and Evolving Strategies in Castration-Sensitive Prostate Cancer (CSPC)
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 30, 2022

Expires: March 29, 2023

View Activity

Faculty

cover img faculity

Atish Choudhury, MD, PhD

Assistant Professor of Medicine
Department of Medicine
Harvard Medical School
Senior Physician
Medical Oncology
Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Michael S. Cookson, MD, MMHC, FACS

Professor and Chair
Department of Urology
The University of Oklahoma Health Sciences Center, College of Medicine
Urologic Oncologist
OU Health Stephenson Cancer Center, Prostate & Urologic Cancers Clinic
OU Health
Oklahoma City, Oklahoma

cover img faculity

David F. Jarrard, MD

Professor and Vice Chair
Department of Urology
John P. Livesey Chair in Urologic Oncology
Associate Director for Translational Research
Carbone Cancer Center
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Myovant Sciences Inc

Pfizer, Inc.